Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
Crossref DOI link: https://doi.org/10.1186/s12935-017-0457-z
Published Online: 2017-10-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Notarangelo, Tiziana
Sisinni, Lorenza
Condelli, Valentina
Landriscina, Matteo
Funding for this research was provided by:
AIRC (Grant IG2015-16738)
Italian Ministry of Health (Grant GR-2010-2310057)